Sunovion Pharmaceuticals v. Teva Pharmaceuticals USA, No. 13-1335 (Fed. Cir. Sept. 26, 2013)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Sunovion Pharmaceuticals, Inc. (“Sunovion”) appeals from the decision of the United States District Court for the District of New Jersey granting summary judgment that Dr. Reddy’s Laboratories, Ltd. and Dr. Reddy’s Laboratories, Inc. (collectively “ Reddy”) do not infringe claims 1, 2, and 8 of Sunovion’s U.S. Patent 6,444,673 (the “’673 patent”). Sunovion Pharm., Inc. v. Teva Ph arm. USA, Inc., No. 09-1302, 2013 WL 211289 (D.N.J. Jan. 17, 2013).